We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ADXS market cap is 666.24k. The company's latest EPS is USD 0.0000 and P/E is N/A.
| Quarter End | Jul 2022 | Oct 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 4k | 9k | 0 |
| Operating Income | -7.29M | -4.85M | -11.87M | -8.49M | -7.13M |
| Net Income | -6.96M | -4.59M | -7.36M | -8.7M | -7.34M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 20.88M | 253k | 3.24M | 250k | 0 |
| Operating Income | -17.97M | -26.45M | -18.79M | -19.31M | 0 |
| Net Income | -16.61M | -26.47M | -17.86M | -15.38M | 0 |
| Quarter End | Jul 2022 | Oct 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.1M | 25.93M | 21M | 12.15M | 6.98M |
| Total Liabilities | 1.91M | 2.3M | 11.32M | 11.14M | 13.22M |
| Total Equity | 28.2M | 23.63M | 9.68M | 1.01M | -6.24M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.26M | 38.53M | 46.78M | 25.93M | 7.77M |
| Total Liabilities | 5.73M | 8.35M | 7.89M | 2.3M | 8.87M |
| Total Equity | 39.53M | 30.18M | 38.89M | 23.63M | -1.1M |
| Quarter End | Jul 2022 | Oct 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.31M | -15.28M | -6.74M | -15.3M | -22.28M |
| Investing | -201k | -166k | N/A | N/A | N/A |
| Financing | -956k | -956k | 21.2M | 20M | 22M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36.13M | -21.94M | -15.44M | -15.28M | N/A |
| Investing | -1.2M | -748k | -11k | -166k | N/A |
| Financing | 24.57M | 15.5M | 31.89M | -956k | N/A |
| Market Cap | 666.24k |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.44 |
| Price to Book Ratio | -9.72 |
| Dividend Yield | - |
| Shares Outstanding | 2.78M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0.8%) |
| Company Name | Advaxis Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.ayalapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
